{"entity":{"type":"insider","cik":"0001514980","url":"/insider/0001514980","json_url":"/insider/0001514980.json","name":"Mueller Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":46,"n_filings":33,"first":"2012-02-14","last":"2024-05-31","span_basis":"filed_date"},"name_variants":[{"name":"Mueller Brian","source":"filing","n_filings":33,"first_seen":"2012-02-14","last_seen":"2024-05-31"}],"transactions":[{"id":2431278,"accession":"0001048477-24-000114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001048477-24-000114","line_url":"/filing/0001048477-24-000114#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":75.19,"price_display":"75.19","price_state":"stated","total_value":375950.0,"total_display":"375,950.00","total_whole":"375,950","shares_owned_after":72159.0,"shares_owned_after_display":"72,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-05-31","scope":"insider"},{"id":8634783,"accession":"0001567619-23-000965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-23-000965","line_url":"/filing/0001567619-23-000965#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":114.5,"price_display":"114.50","price_state":"stated","total_value":286250.0,"total_display":"286,250.00","total_whole":"286,250","shares_owned_after":27746.0,"shares_owned_after_display":"27,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-13","filed_date":"2023-01-17","scope":"insider"},{"id":6790965,"accession":"0001567619-22-021667","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-021667","line_url":"/filing/0001567619-22-021667#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":107.5,"price_display":"107.50","price_state":"stated","total_value":268750.0,"total_display":"268,750.00","total_whole":"268,750","shares_owned_after":27746.0,"shares_owned_after_display":"27,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-15","scope":"insider"},{"id":6188903,"accession":"0001567619-22-021363","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-22-021363","line_url":"/filing/0001567619-22-021363","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7001.0,"shares_display":"7,001","price_per_share":104.5,"price_display":"104.50","price_state":"stated","total_value":731604.5,"total_display":"731,604.50","total_whole":"731,605","shares_owned_after":27746.0,"shares_owned_after_display":"27,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider","n_lines":3},{"id":6869241,"accession":"0001567619-22-020937","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-22-020937","line_url":"/filing/0001567619-22-020937","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5379.0,"shares_display":"5,379","price_per_share":98.73425543781372,"price_display":"98.73","price_state":"stated","total_value":531091.56,"total_display":"531,091.56","total_whole":"531,092","shares_owned_after":28847.0,"shares_owned_after_display":"28,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-28","scope":"insider","n_lines":3},{"id":6731847,"accession":"0001567619-22-015384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-015384","line_url":"/filing/0001567619-22-015384#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":94.5,"price_display":"94.50","price_state":"stated","total_value":330750.0,"total_display":"330,750.00","total_whole":"330,750","shares_owned_after":30726.0,"shares_owned_after_display":"30,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-09","scope":"insider"},{"id":6761720,"accession":"0001567619-22-013907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013907","line_url":"/filing/0001567619-22-013907#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7337.0,"shares_display":"7,337","price_per_share":89.5,"price_display":"89.50","price_state":"stated","total_value":656661.5,"total_display":"656,661.50","total_whole":"656,662","shares_owned_after":30726.0,"shares_owned_after_display":"30,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-12","scope":"insider"},{"id":6784558,"accession":"0001567619-22-009717","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-22-009717","line_url":"/filing/0001567619-22-009717","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11800.0,"shares_display":"11,800","price_per_share":84.5,"price_display":"84.50","price_state":"stated","total_value":997100.0,"total_display":"997,100.00","total_whole":"997,100","shares_owned_after":38639.0,"shares_owned_after_display":"38,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-04","filed_date":"2022-05-06","scope":"insider","n_lines":2},{"id":5075132,"accession":"0001567619-21-009606","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-009606","line_url":"/filing/0001567619-21-009606#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6709.0,"shares_display":"6,709","price_per_share":79.5,"price_display":"79.50","price_state":"stated","total_value":533365.5,"total_display":"533,365.50","total_whole":"533,366","shares_owned_after":31357.0,"shares_owned_after_display":"31,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-07","filed_date":"2021-05-11","scope":"insider"},{"id":4427826,"accession":"0001567619-21-007548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-007548","line_url":"/filing/0001567619-21-007548#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5692.0,"shares_display":"5,692","price_per_share":76.3,"price_display":"76.30","price_state":"stated","total_value":434299.6,"total_display":"434,299.60","total_whole":"434,300","shares_owned_after":31016.0,"shares_owned_after_display":"31,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-02","scope":"insider"},{"id":8336250,"accession":"0001567619-19-008642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-008642","line_url":"/filing/0001567619-19-008642#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2953.0,"shares_display":"2,953","price_per_share":94.0,"price_display":"94.00","price_state":"stated","total_value":277582.0,"total_display":"277,582.00","total_whole":"277,582","shares_owned_after":13660.0,"shares_owned_after_display":"13,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-05","filed_date":"2019-04-09","scope":"insider"},{"id":6532407,"accession":"0001567619-18-000239","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-18-000239","line_url":"/filing/0001567619-18-000239#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":104.5,"price_display":"104.50","price_state":"stated","total_value":261250.0,"total_display":"261,250.00","total_whole":"261,250","shares_owned_after":12375.0,"shares_owned_after_display":"12,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-07","filed_date":"2018-08-09","scope":"insider"},{"id":6445059,"accession":"0001140361-18-030005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-030005","line_url":"/filing/0001140361-18-030005","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3145.0,"shares_display":"3,145","price_per_share":99.5,"price_display":"99.50","price_state":"stated","total_value":312927.5,"total_display":"312,927.50","total_whole":"312,928","shares_owned_after":12375.0,"shares_owned_after_display":"12,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-22","filed_date":"2018-06-26","scope":"insider","n_lines":2},{"id":6411325,"accession":"0001140361-18-029042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-029042","line_url":"/filing/0001140361-18-029042#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2021.0,"shares_display":"2,021","price_per_share":94.5,"price_display":"94.50","price_state":"stated","total_value":190984.5,"total_display":"190,984.50","total_whole":"190,985","shares_owned_after":13029.0,"shares_owned_after_display":"13,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-18","scope":"insider"},{"id":6577208,"accession":"0001140361-18-023458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-023458","line_url":"/filing/0001140361-18-023458#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2450.0,"shares_display":"2,450","price_per_share":89.5,"price_display":"89.50","price_state":"stated","total_value":219275.0,"total_display":"219,275.00","total_whole":"219,275","shares_owned_after":15396.0,"shares_owned_after_display":"15,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-10","filed_date":"2018-05-14","scope":"insider"},{"id":4189613,"accession":"0001140361-17-026024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-026024","line_url":"/filing/0001140361-17-026024#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2671.0,"shares_display":"2,671","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":267100.0,"total_display":"267,100.00","total_whole":"267,100","shares_owned_after":12885.0,"shares_owned_after_display":"12,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-22","filed_date":"2017-06-23","scope":"insider"},{"id":4172286,"accession":"0001140361-17-019306","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-019306","line_url":"/filing/0001140361-17-019306","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (SVP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (SVP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7482.0,"shares_display":"7,482","price_per_share":91.86500133654103,"price_display":"91.87","price_state":"stated","total_value":687333.94,"total_display":"687,333.94","total_whole":"687,334","shares_owned_after":13468.0,"shares_owned_after_display":"13,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-08","filed_date":"2017-05-10","scope":"insider","n_lines":2},{"id":2965139,"accession":"0001140361-16-074507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-074507","line_url":"/filing/0001140361-16-074507#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":287.0,"shares_display":"287","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":28700.0,"total_display":"28,700.00","total_whole":"28,700","shares_owned_after":14260.0,"shares_owned_after_display":"14,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":8841902,"accession":"0001140361-15-010553","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-010553","line_url":"/filing/0001140361-15-010553#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":109.4585,"price_display":"109.46","price_state":"stated","total_value":766209.5,"total_display":"766,209.50","total_whole":"766,210","shares_owned_after":8800.0,"shares_owned_after_display":"8,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-03","filed_date":"2015-03-05","scope":"insider"},{"id":6262017,"accession":"0001140361-14-044048","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-14-044048","line_url":"/filing/0001140361-14-044048#line-5","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":91.82,"price_display":"91.82","price_state":"stated","total_value":459100.0,"total_display":"459,100.00","total_whole":"459,100","shares_owned_after":4593.0,"shares_owned_after_display":"4,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-03","scope":"insider"},{"id":6262013,"accession":"0001140361-14-044048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-14-044048","line_url":"/filing/0001140361-14-044048#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6950.0,"shares_display":"6,950","price_per_share":90.25,"price_display":"90.25","price_state":"stated","total_value":627237.5,"total_display":"627,237.50","total_whole":"627,238","shares_owned_after":4593.0,"shares_owned_after_display":"4,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":6739866,"accession":"0001140361-14-043929","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-043929","line_url":"/filing/0001140361-14-043929#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3400.0,"shares_display":"3,400","price_per_share":88.973,"price_display":"88.97","price_state":"stated","total_value":302508.2,"total_display":"302,508.20","total_whole":"302,508","shares_owned_after":4593.0,"shares_owned_after_display":"4,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-12-02","scope":"insider"},{"id":4418906,"accession":"0001140361-13-020906","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-13-020906","line_url":"/filing/0001140361-13-020906","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4947.0,"shares_display":"4,947","price_per_share":70.35471629270265,"price_display":"70.35","price_state":"stated","total_value":348044.7815,"total_display":"348,044.78","total_whole":"348,045","shares_owned_after":6660.0,"shares_owned_after_display":"6,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-15","scope":"insider","n_lines":2},{"id":4528525,"accession":"0001140361-13-019035","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-13-019035","line_url":"/filing/0001140361-13-019035#line-6","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":67.106,"price_display":"67.11","price_state":"stated","total_value":503295.0,"total_display":"503,295.00","total_whole":"503,295","shares_owned_after":9403.0,"shares_owned_after_display":"9,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-03","filed_date":"2013-05-06","scope":"insider"},{"id":4528516,"accession":"0001140361-13-019035","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-13-019035","line_url":"/filing/0001140361-13-019035","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9331.0,"shares_display":"9,331","price_per_share":65.41143875254528,"price_display":"65.41","price_state":"stated","total_value":610354.135,"total_display":"610,354.14","total_whole":"610,354","shares_owned_after":13860.0,"shares_owned_after_display":"13,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-02","filed_date":"2013-05-06","scope":"insider","n_lines":2},{"id":4836831,"accession":"0001140361-13-010494","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-13-010494","line_url":"/filing/0001140361-13-010494#line-5","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5023.0,"shares_display":"5,023","price_per_share":59.7386,"price_display":"59.74","price_state":"stated","total_value":300066.9878,"total_display":"300,066.99","total_whole":"300,067","shares_owned_after":15294.0,"shares_owned_after_display":"15,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-01","filed_date":"2013-03-04","scope":"insider"},{"id":4836824,"accession":"0001140361-13-010494","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-13-010494","line_url":"/filing/0001140361-13-010494#line-4","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2015.0,"shares_display":"2,015","price_per_share":59.8065,"price_display":"59.81","price_state":"stated","total_value":120510.0975,"total_display":"120,510.10","total_whole":"120,510","shares_owned_after":13279.0,"shares_owned_after_display":"13,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-01","filed_date":"2013-03-04","scope":"insider"},{"id":3384543,"accession":"0001140361-12-048038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-12-048038","line_url":"/filing/0001140361-12-048038#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15812.0,"shares_display":"15,812","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":790600.0,"total_display":"790,600.00","total_whole":"790,600","shares_owned_after":15340.0,"shares_owned_after_display":"15,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-15","filed_date":"2012-11-19","scope":"insider"},{"id":3530868,"accession":"0001140361-12-046031","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-12-046031","line_url":"/filing/0001140361-12-046031","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":47.03125,"price_display":"47.03","price_state":"stated","total_value":376250.0,"total_display":"376,250.00","total_whole":"376,250","shares_owned_after":15340.0,"shares_owned_after_display":"15,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-05","filed_date":"2012-11-07","scope":"insider","n_lines":2},{"id":4869722,"accession":"0001140361-13-006978","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-13-006978","line_url":"/filing/0001140361-13-006978#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":548.0,"shares_display":"548","price_per_share":21.76,"price_display":"21.76","price_state":"stated","total_value":11924.48,"total_display":"11,924.48","total_whole":"11,924","shares_owned_after":15294.0,"shares_owned_after_display":"15,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-31","filed_date":"2013-02-14","scope":"insider"},{"id":3354156,"accession":"0001140361-12-032909","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-032909","line_url":"/filing/0001140361-12-032909#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":42.5,"price_display":"42.50","price_state":"stated","total_value":106250.0,"total_display":"106,250.00","total_whole":"106,250","shares_owned_after":15340.0,"shares_owned_after_display":"15,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-10","filed_date":"2012-07-11","scope":"insider"},{"id":3418704,"accession":"0001140361-12-032452","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-032452","line_url":"/filing/0001140361-12-032452#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2770.0,"shares_display":"2,770","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":110800.0,"total_display":"110,800.00","total_whole":"110,800","shares_owned_after":15340.0,"shares_owned_after_display":"15,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-02","filed_date":"2012-07-05","scope":"insider"},{"id":9232037,"accession":"0001140361-12-024700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-024700","line_url":"/filing/0001140361-12-024700#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15708.0,"shares_display":"15,708","price_per_share":37.5,"price_display":"37.50","price_state":"stated","total_value":589050.0,"total_display":"589,050.00","total_whole":"589,050","shares_owned_after":13684.0,"shares_owned_after_display":"13,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-08","filed_date":"2012-05-11","scope":"insider"},{"id":2637688,"accession":"0001140361-12-024276","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001140361-12-024276","line_url":"/filing/0001140361-12-024276#line-8","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15708.0,"shares_display":"15,708","price_per_share":37.5,"price_display":"37.50","price_state":"stated","total_value":589050.0,"total_display":"589,050.00","total_whole":"589,050","shares_owned_after":13684.0,"shares_owned_after_display":"13,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-08","filed_date":"2012-05-10","scope":"insider"},{"id":2559334,"accession":"0001140361-12-011406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-011406","line_url":"/filing/0001140361-12-011406#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":35.065,"price_display":"35.06","price_state":"stated","total_value":175325.0,"total_display":"175,325.00","total_whole":"175,325","shares_owned_after":8300.0,"shares_owned_after_display":"8,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-24","filed_date":"2012-02-28","scope":"insider"},{"id":2291005,"accession":"0001140361-12-008335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-12-008335","line_url":"/filing/0001140361-12-008335#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001514980","owner_name":"Mueller Brian","owner_display_name":"Mueller Brian","owner_url":"/insider/0001514980","role":"Officer (VP, Corporate Controller)","role_mark":"O","role_mark_label":"Officer (VP, Corporate Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Corporate Controller","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":964.0,"shares_display":"964","price_per_share":13.226,"price_display":"13.23","price_state":"stated","total_value":12749.864,"total_display":"12,749.86","total_whole":"12,750","shares_owned_after":8300.0,"shares_owned_after_display":"8,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-31","filed_date":"2012-02-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":46,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":44,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":46},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001048477","name":"BIOMARIN PHARMACEUTICAL INC","url":"/issuer/0001048477","role":"Officer (EVP, Chief Financial Officer)","n_filings":33,"first_seen":"2012-02-14","last_seen":"2024-05-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001514980","retrieved_at":"2026-08-23T17:52:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}